Cannabis use may be associated with a higher risk of deep vein thrombosis, cardiovascular issues and other complications after total joint replacement, according to a Cleveland Clinic study.
A nationwide survey of people with MS finds a sizeable minority have used cannabis for their condition but few rely on their physicians for information about it.
A pooled analysis of three randomized trials of nabiximols helps lay the groundwork for an FDA submission in 2021. Approval would yield the first novel treatment for spasticity in multiple sclerosis in many years.
Fearmongering over “reefer madness” is overblown, but concerns about widespread amotivation, worsening psychiatric states, chronic disability and chemical dependence are very real.